Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial

Go Back to All Clinical Trials

Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial

Brief description of study

The purpose of this research study is to see if a medication called clozapine helps to reduce violence in people with schizophrenia. The study will assign participants by chance (like flipping a coin) to receive either clozapine or a different antipsychotic drug assigned by their doctor. The study will last about 24 weeks and involves around 26 visits. While in this study, you will be asked to come in for weekly visits, take antipsychotic medication, and participate in blood draws, questionnaires, urine samples, and medical monitoring. At each appointment we will also ask to speak with an individual you identify as being familiar with your behavior in the community since the last assessment. Study staff will reach out to this informant and collect information about violence, suicidality, and symptoms as needed.

Clinical Study Identifier: s20-02054

ClinicalTrials.gov Identifier: NCT05208190

Principal Investigator: Donald C Goff.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies